Integer Holdings Corporation (NYSE:ITGR) Stock Has Average Price Target of $109.86 According to Analysts

Integer Holdings Corporation (NYSE:ITGR) has been given an average recommendation of “Hold” by the fourteen brokerages that are covering the stock, MarketBeat Ratings reports. Thirteen analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $109.86.

ITGR has been the topic of several analyst reports. Benchmark cut Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. Truist Financial downgraded shares of Integer from a “buy” rating to a “hold” rating and upped their price objective for the stock from $110.00 to $127.00 in a research report on Monday, August 3rd. Raymond James Financial downgraded shares of Integer from a “moderate buy” rating to a “hold” rating in a research report on Monday, August 3rd. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a research report on Monday, September 14th.

Integer Trading Up 0.0%

NYSE:ITGR opened at $126.63 on Thursday. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. Integer has a one year low of $62.00 and a one year high of $126.79. The company has a market cap of $4.31 billion, a PE ratio of 34.60, a PEG ratio of 2.41 and a beta of 0.58. The firm has a 50-day moving average of $125.91 and a 200-day moving average of $103.99.

Integer (NYSE:ITGR) last released its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. The business had revenue of $464.11 million during the quarter, compared to the consensus estimate of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%. The company’s quarterly revenue was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.55 EPS. As a group, equities research analysts expect that Integer will post 6.09 EPS for the current fiscal year.

Insider Buying and Selling

In other Integer news, insider Kirk K. Thor sold 11,767 shares of the business’s stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $126.23, for a total value of $1,485,348.41. Following the transaction, the insider owned 7,153 shares of the company’s stock, valued at approximately $902,923.19. The trade was a 62.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Andrew Senn sold 9,408 shares of the business’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $126.30, for a total value of $1,188,230.40. Following the completion of the transaction, the insider directly owned 5,405 shares in the company, valued at approximately $682,651.50. This represents a 63.51% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 40,948 shares of company stock valued at $5,169,920 over the last ninety days. 1.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Integer

Several large investors have recently made changes to their positions in the business. Heartland Advisors Inc. increased its holdings in Integer by 506.8% in the 4th quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock worth $19,036,000 after acquiring an additional 202,715 shares during the last quarter. HBK Investments L P bought a new stake in Integer in the 2nd quarter valued at about $14,502,000. Hsbc Holdings PLC purchased a new stake in Integer during the second quarter valued at about $3,292,000. Assenagon Asset Management S.A. purchased a new stake in Integer during the second quarter valued at about $746,000. Finally, Great Lakes Advisors LLC bought a new position in Integer during the second quarter worth about $2,396,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a medical device contract development and manufacturing company. The company designs, develops and manufactures components and finished products for medical device manufacturers, helping customers bring products from concept and development through commercial production.

Integer’s products and technologies support a range of medical applications, including cardiac and vascular devices, neuromodulation systems, orthopedics, and other specialty medical products.